<DOC>
	<DOCNO>NCT02732704</DOCNO>
	<brief_summary>The purpose research study collect information new treatment severe aortic regurgitation , affect aortic valve heart . Aortic regurgitation condition heart 's aortic valve close tightly allow blood leak back heart chamber . Symptoms aortic regurgitation may include fatigue shortness breath . The preferred treatment severe aortic regurgitation aortic valve replacement surgery . A less invasive surgical approach call TAVR offer patient high risk undergo open heart surgery replace aortic valve . In study , TAVR perform use JenaValve Pericardial TAVR System , intend help treat severe aortic regurgitation . The JenaValve replacement valve place inside aortic valve use JenaValve delivery system . The JenaValve replacement valve may implant one two way : ( 1 ) transapical - valve implant chest wall , ( 2 ) transfemoral - valve implanted artery groin . The choice implant method use decide doctor .</brief_summary>
	<brief_title>JenaValve Pericardial TAVR Aortic Regurgitation Study</brief_title>
	<detailed_description />
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<criteria>Patient severe aortic regurgitation ( AR ) . Patient high risk open surgical valve replacement Patient symptomatic accord NYHA functional class II high Congenital uni bicuspid aortic valve morphology Previous prosthetic aortic valve ( bioprosthesis mechanical ) implant Endocarditis active infection Need urgent emergent TAVR procedure reason Cardiogenic shock hemodynamic instability require inotropic support ventricular assist device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>